Lysinibacillus sphaericus and aspirin chemoprevention of colorectal cancer
US12275995B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2020 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Feb 15, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2531/113
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides methods for assessing the likelihood of effectiveness of aspirin-based chemoprotection against colorectal cancer among individuals as well as methods for improving aspirin-based chemoprotection against colorectal cancer. Kits useful for such methods are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.